{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:56:36Z","timestamp":1777485396416,"version":"3.51.4"},"reference-count":57,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Hepatol"],"abstract":"<jats:p>Gallstone disease (cholelithiasis) is a common gastrointestinal (GI) disorder characterized by the accumulation of hardened bile constituents, often leading to complications such as cholecystitis, cholangitis, and pancreatitis. Most gallstones are cholesterol-based and form due to bile supersaturation, gallbladder dysmotility, and inflammation. Current treatment options\u2013such as ursodeoxycholic acid, laparoscopic cholecystectomy, and dietary modifications\u2013have limitations including invasiveness, prolonged duration, side effects, and recurrence risk. Melatonin, a hormone secreted by the pineal gland, has gained attention for its antioxidant and anti-inflammatory properties, as well as its regulatory effects on lipid metabolism and gallbladder motility. Experimental studies suggest that melatonin reduces biliary cholesterol, suppresses oxidative stress, and restores gallbladder muscle function, thereby preventing gallstone formation. It is also present in bile and shown to enhance cholesterol conversion into bile acids and inhibit intestinal cholesterol absorption. Beyond gallstone prevention, melatonin demonstrates protective effects against GI malignancies, including hepatocellular carcinoma and cholangiocarcinoma, by regulating mitochondrial function, inhibiting glycolysis, and modulating apoptosis. With a strong safety profile and minimal side effects, melatonin may serve as a promising adjunct or alternative for gallstone management, particularly in patients unfit for surgery. Further clinical research is warranted to validate its therapeutic role.<\/jats:p>","DOI":"10.4254\/wjh.v17.i9.110964","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T06:43:18Z","timestamp":1758782598000},"source":"Crossref","is-referenced-by-count":1,"title":["Melatonin\u2019s anti-inflammatory and antioxidant effects in gallstone disease: A narrative review"],"prefix":"10.4254","volume":"17","author":[{"given":"Umaimah","family":"Batool Mirza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imteshal","family":"Sarfaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunaira","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniyal","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Asad","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abedin","family":"Samadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"B1","unstructured":"Cleveland Clinic.   Gallstones [Internet]. 2023 [cited 5 May 2025]. Available from: https:\/\/my.clevelandclinic.org\/health\/diseases\/7313-gallstones"},{"key":"B2","unstructured":"ScienceDirect.   Gallstone-Classification of Gallstones [Internet]. [cited 5 May 2025]. Available from: https:\/\/www.sciencedirect.com\/topics\/pharmacology-toxicology-and-pharmaceutical"},{"key":"B3","unstructured":"Jones MW, Weir CB, Marietta M.   Gallstones (Cholelithiasis). 2025 Jun 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074887"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2010.02.003"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/SGA.0000000000000235"},{"key":"B7","unstructured":"Metz L.   Weight stigma and the five F\u2019s of gallstone disease [Internet]. Mosaic Comprehensive Care, 2019. [cited 5 May 2025]. Available from: https:\/\/mosaiccarenc.com\/uncategorized\/weight-stigma-and-the-five-fs-of-gallstone-disease\/"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1615\/jlongtermeffmedimplants.v15.i3.90"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-001-0015-6"},{"key":"B10","unstructured":"Heuman DM.   Gallstones (cholelithiasis) [Internet]. 2023. [cited 5 May 2025]. Available from: https:\/\/emedicine.medscape.com\/article\/175667-overview?form=fpf"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03355-z"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12734"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1978.234.1.E44"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24702"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.06.006"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02407-8"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i10.1589"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000515545"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2011.07.015"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2006.04.005"},{"key":"B21","unstructured":"University of Illinois.   Ezetimibe: Side effects, dosage, uses, and more [Internet]. Healthline, 2018. [cited 5 May 2025]. Available from: https:\/\/www.healthline.com\/health\/drugs\/ezetimibe-oral-tablet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5009\/gnl.2012.6.2.172"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4547"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210309"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69044-2"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006231"},{"key":"B27","unstructured":"Strasberg SM, Hertl M, Soper NJ. An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg 1995; 101-125"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.6.863"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(05)80930-4"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802183180701"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/80.1.38"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000066"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuchi.2015.03.002"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103480"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02708-6"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02673.x"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2022.05.011"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02760-0"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1339304"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/molecules201018886"},{"key":"B41","unstructured":"Popov SS, Pashkov AN, Zoloedov VI, Shvedov GI. [The use of melatonin in combined therapy of drug-induced hepatitis]. Klin Med (Mosk) 2013; 50-53"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166281"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122800"},{"key":"B44","unstructured":"Thor PJ, Krolczyk G, Gil K, Zurowski D, Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J Physiol Pharmacol 2007; 97-103"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010218"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2174\/092986710793348536"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-079x.2003.00095.x"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.2007.00520.x"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0195-5"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12068"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1066698"},{"key":"B52","unstructured":"Yan JJ, Shen F, Wang K, Wu MC. Patients with advanced primary hepatocellular carcinoma treated by melatonin and transcatheter arterial chemoembolization: a prospective study. Hepatobiliary Pancreat Dis Int 2002; 183-186"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26586"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2022.55.9.177"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02385-w"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121530"},{"key":"B57","unstructured":"Lissoni P, Rovelli F, Malugani F, Bucovec R, Conti A, Maestroni GJ. Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Lett 2001; 45-47"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i9\/110964.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i9\/110964.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T06:43:59Z","timestamp":1758782639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i9\/110964.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":57,"journal-issue":{"issue":"9"},"alternative-id":["110964"],"URL":"https:\/\/doi.org\/10.4254\/wjh.v17.i9.110964","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,27]]}}}